Amycretin vs Tirzepatide

Molecule comparison

Last updated 2026-05-28 15:46 UTC

Amycretin is an experimental drug that combines signals for two hormones, amylin and GLP-1, and is not yet approved for any use. Tirzepatide, sold as Mounjaro or Zepbound, is an approved drug that works on two hormones, GIP and GLP-1, and is cleared to treat type 2 diabetes, obesity, and obstructive sleep apnea.

AI summary of the sources below.

	Amycretin	Tirzepatide
Mechanism	Amylin and GLP-1 receptor co-agonist	GIP and GLP-1 receptor dual agonist
Status	Pipeline	Approved
Branded products	—	mounjaro, zepbound

Compare full details on the Amycretin and Tirzepatide pages.